IP Library Granted Patent US 8,361,517
Granted Patent B2
US 8,361,517 · App. 12/738,116 · Granted Jan 29, 2013

Composition for regulating lipid metabolism

Inventors: Marie Francoise Yvonne Bourgeois-Lugand (Loqueffret, FR); Walter Wahli (Echichens, CH); Ilhem El Kochairi (Lausanne, CH); Sylvain Pradervand (Chavannes-Renens, CH); Giles Didier Parisot (Ollon, CH)
Assignee: Actigenomics S.A.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,361,517
App. No.
12/738,116
Granted
Jan 29, 2013
Kind
B2
Abstract

This invention concerns a composition for regulating lipid metabolism and methods that may be used in the food industry as well as in the nutraceutical and therapeutic fields. In particular, the invention involves food additives or supplements, a composition containing these and the use thereof, in particular for revitalizing a subject's metabolism, in particular, that of human beings.

Claims (39)

1. A composition designed to regulate lipid metabolism in humans and animals comprising, per 100 g or 100 ml, the combination of:

a) 7 μg to 700 μg of at least two plant oils selected from the group consisting of rapeseed oil, olive oil, grape seed oil, and evening primrose oil;

b) 10 μg to 1000 μg of positively charged minerals selected from the group consisting of sodium, magnesium, and calcium;

c) 10 μg to 1000 μg of metals selected from the group consisting of zinc and iron;

d) 7 μg to 700 μg of yeast or yeast extracts from genus Saccharomyces , characterized in that said yeasts or yeast extracts are enriched with selenium;

e) 7 μg to 700 μg of mycelium or mycelium extracts obtained from Shiitake;

f) 6 μg to 600 μg of at least two vegetable extracts selected from the group consisting of samphire, garlic, and grapevine;

g) 8 μg to 800 μg of at least one vitamin selected from the group consisting of vitamins A, B1, B9, C, E, F, and PP;

h) 7 μg to 700 μg of an animal oil and Copra oil;

i) 6 μg to 600 μg of at least one alga selected from the group consisting of Palmaria palmate, Chondrus crispus, Fucus vesiculosus , and a pharmaceutically and/or nutritionally acceptable excipient.

2. The composition designed to regulate lipid metabolism in humans and animals according to claim 1 , wherein the animal oil consists of cold water fish oil.

3. The composition designed regulate lipid metabolism in humans and animals according to claim 1 , wherein said composition contains at least two vitamins selected from the group consisting of vitamins A, B1, B9, C, E, F, and PP.

4. The composition according to claim 1 , wherein the composition comprises per 100 g or 100 ml, the combination of:

a) 7 μg to 700 μg of rapeseed oil, olive oil, grape seed oil, and evening primrose oil;

b) 10 μg to 1000 μg of sodium, magnesium, and calcium;

c) 10 μg to 1000 μg of zinc and iron;

d) 7 μg to 700 μg of yeasts or yeast extracts obtained from Saccharomvces cerevisiae , enriched with selenium;

e) 7 μg to 700 μg of mycelium or mycelium extracts obtained from Shiitake,

f) 6 μg to 600 μg of samphire, garlic, and grapevine;

g) 8 μg to 800 μg of vitamins A, B1, B9, C, E, F, and PP;

h) 7 μg to 700 μg of cold water fish oil and Copra oil, and

i) 6 μg to 600 μg of Palmaria palmate, Chondrus crispus , and Fucus vesiculosus .

5. The composition according to claim 1 , wherein the composition further comprises excipients or additives.

6. The composition according to claim 1 , wherein the composition is in the form of a solid, liquid, oil, gel, strip, paste, powder, or gum.

7. The composition according to claim 1 , wherein the composition is suitable for oral administration.

8. The composition according to claim 1 , wherein the composition is in the form of a food or a drink with the further addition of a supplement or a food additive.

9. The composition according to claim 1 , for use as a medicament.

10. The composition according to claim 1 , wherein the yeast or yeast extracts are from Saccharomyces cerevisiae .

11. A medicament comprising the composition of claim 1 .

12. A food additive comprising the composition of claim 1 .

13. A nutritional supplement comprising the composition of claim 1 .

14. A cosmetic comprising the composition of claim 1 .

15. The composition according to claim 5 , wherein the additives are selected from the group consisting of sweeteners, stabilizing agents, preservatives, dyes, emulsifiers or gelling agents, flavor enhancers, acidifiers, and flavors.

16. A method of regulating lipid metabolism in humans and animal, said method comprising administering an effective amount of the composition according to claim 1 to a subject in need thereof to reduce one or more of the following:

plasma cholesterol level, plasma LDL level, or plasma triglyceride level.

17. A method of treating obesity comprising administering an effective amount of the composition according to claim 1 to a subject in need thereof to stimulate lipid consumption.

18. A method of treating obesity comprising administering an effective amount of the composition according to claim 1 to a subject in need thereof to reduce intestinal absorption of food lipid.

19. A method of improving physical endurance, said method comprising administering an effective amount of the composition according to claim 1 to a subject in need thereof to increase oxidative metabolism and oxygen uptake.

20. A method of increasing muscle motility, said method comprising administering an effective amount of the composition according to claim 1 to a subject in need thereof to increase oxidative metabolism and oxygen uptake.

Assignments (5)
CHANGE OF NAME Recorded Feb 11, 2013
From: EXICHOL SA
To: ACTIGENOMICS S.A.
Reel/Frame 029787/0111 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 11, 2013
From: KOCHAIRI, ILHEM EL
To: ACTIGENOMICS S.A.
Reel/Frame 029787/0489 →
CORRECTIVE ASSIGNMENT TO CORRECT THE GILES DIDIER PARISOT PREVIOUSLY RECORDED ON REEL 029490 FRAME 0990. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNOR NAME: GILLES DIDIER PARISOT. Recorded Feb 8, 2013
From: PARISOT, GILLES DIDIER
To: EXICHOL SA
Reel/Frame 029778/0309 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 18, 2012
From: BOURGEOIS, MARIE FRANCOISE YVONNE; PRADERVAND, SYLVAIN; WAHLI, WALTER; PARISOT, GILES DIDIER
To: EXICHOL SA
Reel/Frame 029490/0990 →
CHANGE OF NAME Recorded Dec 18, 2012
From: EXICHOL SA
To: ACTIGENOMICS S.A.
Reel/Frame 029493/0055 →
Priority Claims (1)
EP 07118598 · Oct 16, 2007 · regional
Continuity (1)
Related Publication 20100215761A1 · Aug 26, 2010